Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab

Coronavirus disease 2019 (COVID-19) can progress to cytokine storm that is associated with organ dysfunction and death. The purpose of the present study is to determine clinical characteristics associated with 28 day in-hospital survival in patients with coronavirus disease 2019 (COVID-19) that rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Austin R., Johnson, Joseph M., Griebe, Kristin M., Jones, Mathew C., Stine, John J., Hencken, Laura N., To, Long, Bianchini, Monica L., Vahia, Amit T., Swiderek, Jennifer, Ramesh, Mayur S., Peters, Michael A., Smith, Zachary R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332925/
https://www.ncbi.nlm.nih.gov/pubmed/32646770
http://dx.doi.org/10.1016/j.jaut.2020.102512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332925/
https://www.ncbi.nlm.nih.gov/pubmed/32646770
http://dx.doi.org/10.1016/j.jaut.2020.102512

Ejemplares similares